Electromed (NSDQ:ELMD) shares ticked up today on second-quarter results that topped the consensus earnings forecast. The New Prague, Minn.-based airway clearance therapy technology developer posted profits of $1.2 million, or 13¢ per share, on sales of $9.5 million for the three months ended Dec. 31, 2020, for a 1.6% bottom-line gain on sales growth of 11.1%. […]
Electromed
Electromed beats The Street’s EPS projections
Electromed (NSDQ:ELMD) shares dipped today despite first-quarter EPS results that topped the consensus forecast. The New Prague, Minn.-based airway clearance therapy technology developer posted profits of $535,262, or 6¢ per share, on sales of $8 million for the three months ended Sept. 30, 2020, for a -47.2% bottom-line slide on a sales decline of -3.6%. Adjusted […]
Electromed posts Street-beating Q4
Electromed (NSDQ:ELMD) shares dipped slightly today despite fourth-quarter results that topped the consensus forecast. The New Prague, Minn.-based airway clearance therapy technology developer posted profits of $1.3 million, or 15¢ per share, on sales of $6.9 million for the three months ended June 30, 2020, for a 20.1% bottom-line gain despite a sales decline of -20.1%. […]
Electromed appoints new chief financial officer
Electromed has appointed Michael MacCourt as chief financial officer. MacCourt brings nearly two decades of financial leadership and multidimensional business experience in medical devices to the company, Electromed said yesterday. Prior to joining Electromed, MacCourt was the senior director of commercial finance at Starkey Hearing Technologies. He has also spent over nine years in leadership […]
Medtech 100 roundup: Stocks dip slightly after strong start to month
Medtech stocks ticked down over the course of last week as the COVID-19 pandemic continues to bear economic ramifications. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — sat at 82.4 points at the end of last week (May 15). That total represents a -1.9% decline from the 83.98-point […]
Electromed down despite Street-beating Q3 sales
Electromed (NSDQ:ELMD) shares ticked down today on third-quarter results that came out on top of the consensus revenue forecast. The New Prague, Minn.-based airway clearance therapy technology developer posted profits of $653,274, or 7¢ per share, on sales of $8.7 million for the three months ended March 31, 202o, for an 85.1% bottom-line gain on sales […]
Electromed launches SmartVest mobile app
Electromed (NSDQ:ELMD) announced that it launched the SmartVest Connect app for personalized high-frequency chest wall oscillation (HFCWO) therapy management for people with compromised pulmonary function. The app, available on iOS and Android platforms, is designed to securely connect to the SmartVest SQL through Bluetooth technology and allow patients and healthcare teams to track therapy in real-time […]
Electromed beats The Street in Q1 results
Electromed (NSDQ:ELMD) posted first-quarter results today that beat the consensus forecast on Wall Street. The New Prague, Minn.-based company reported profits of $1 million, or 12¢ per share, on sales of $8.3 million for the three months ended Sept. 30, 2019, for a bottom-line gain of 536.1% sales growth of 13.7% compared with Q1 2019. Adjusted […]
Electromed inks distro deals for SmartVest
Electromed (NSDQ:ELMD) announced agreements with two unnamed home medical equipment distributors for the sale and distribution of its SmartVest airway clearance system in the U.S. The distributors – one regional and one national – will sell directly to patients, according to a release. Electromed said it expects minimal impact to fiscal 2020 revenues and expenses […]
DaVita taps Javier Rodriguez as CEO | Personnel Moves – April 29, 2019
DaVita Healthcare (NYSE:DVA) said today that its board of directors unanimously elected Javier Rodriguez to succeed Kent Thiry as its new CEO, effective June 1. The Denver-based company said that former CEO Thiry will transition to serve as executive chairman of the board, and that the announcement comes as part of a multi-year succession planning process. […]
Electromed touts SmartVest non-cystic fybrosis bronchiectasis study data
Electromed (NSDQ:ELMD) today released results from an independent clinical study exploring the use of high frequency chest wall oscillation therapy with its SmartVest, touting that it significantly reduced severe exacerbations and hospitalizations for non-cystic fibrosis bronchiectasis patients. Findings from the study were presented at the World Bronchiectasis Conference in Washington D.C., the New Prague, Minn.-based company said. […]
